Financial Ratios

EIKO LIFESCIENCES LTD.

NSE : NABSE : 540204ISIN CODE : INE666Q01016Industry : ChemicalsHouse : Private
BSE57.801.46 (+2.59 %)
PREV CLOSE ( ) 56.34
OPEN PRICE ( ) 56.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 21568
TODAY'S LOW / HIGH ( )53.35 57.80
52 WK LOW / HIGH ( ) 46.7981.32
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)0.920.851.610.330.19
   CEPS(Rs)1.461.321.530.430.30
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)35.3834.4316.1914.3514.21
   Tax Rate(%)25.0825.0826.231.7527.21
Margin Ratios
   Core EBITDA Margin(%)5.245.154.3647.01
   EBIT Margin(%)6.455.587.6936.01
   Pre Tax Margin(%)5.603.716.9427.24
   PAT Margin (%)4.202.785.1219.83
   Cash Profit Margin (%)7.654.995.6436.72
Performance Ratios
   ROA(%)2.332.745.512.231.23
   ROE(%)2.654.0510.532.341.32
   ROCE(%)3.775.969.183.462.25
   Asset Turnover(x)0.560.991.080.000.06
   Sales/Fixed Asset(x)1.203.2523.280.000.71
   Working Capital/Sales(x)2.263.951.780.000.58
Efficiency Ratios
   Fixed Capital/Sales(x)0.830.310.041.41
   Receivable days116.2357.29103.9584.79
   Inventory Days63.4039.651.930.00
   Payable days27.1526.2132.59
Valuation Parameters
   PER(x)71.6549.5349.2530.34301.21
   PCE(x)45.3531.8144.7620.47162.67
   Price/Book(x)2.161.414.890.714.02
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)3.441.762.3460.53
   EV/Core EBITDA(x)34.7122.5828.4815.82114.43
   EV/EBIT(x)53.2831.5430.3920.73168.12
   EV/CE(x)2.031.281.690.723.84
   M Cap / Sales3.471.592.5259.74
Growth Ratio
   Net Sales Growth(%)-27.90111.93-100.00-25.99
   Core EBITDA Growth(%)-8.37101.46277.8034.88-41.40
   EBIT Growth(%)-16.6553.92363.9951.25-50.93
   PAT Growth(%)8.9414.88380.6976.64-60.41
   EPS Growth(%)8.93-47.23380.7576.61-60.41
Financial Stability Ratios
   Total Debt/Equity(x)0.000.160.300.050.06
   Current Ratio(x)7.762.072.701.198.94
   Quick Ratio(x)7.001.162.691.198.94
   Interest Cover(x)7.572.9810.352.904.11
   Total Debt/Mcap(x)0.000.110.060.070.01

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.